Ikena Oncology, Inc.IKNANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P4
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -66.40% |
| Q3 2025 | 286.53% |
| Q2 2025 | 8.34% |
| Q1 2025 | -18.89% |
| Q4 2024 | -32.82% |
| Q3 2024 | -30.00% |
| Q2 2024 | 3.33% |
| Q1 2024 | -32.52% |
| Q4 2023 | 1078.82% |
| Q3 2023 | -92.19% |
| Q2 2023 | -2.44% |
| Q1 2023 | -0.56% |
| Q4 2022 | -17.03% |
| Q3 2022 | 21.71% |
| Q2 2022 | 7.98% |
| Q1 2022 | 16.25% |
| Q4 2021 | -7.75% |
| Q3 2021 | 17.59% |
| Q2 2021 | 13.50% |
| Q1 2021 | -57.18% |
| Q4 2020 | 224.22% |
| Q3 2020 | 13.96% |
| Q2 2020 | -19.75% |
| Q1 2020 | 32.34% |
| Q4 2019 | 0.00% |